IQV | Jotup

IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024

Retrieved on:

Jeudi, mai 9, 2024

Software, Research, Professional Services, Pharmaceutical, Data Management, Technology, Security, Health Technology, Data Analytics, Science, Biotechnology, Health, IQVIA, Webcast, Bank, Conference, IQV

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m.
ET (9:20 a.m. local PT).
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com .
A replay of the webcast will be available later that day.

IQVIA Reports First-Quarter 2024 Results

Retrieved on:

Jeudi, mai 2, 2024

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
As of March 31, 2024, R&DS contracted backlog, including reimbursed expenses, was $30.1 billion, growing 7.9 percent year-over-year and 8.3 percent at constant currency.
“The IQVIA team executed well in the first quarter, including strong bookings and robust free cash flow generation,” stated Ari Bousbib, chairman and CEO of IQVIA.
IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its first-quarter 2024 results and its second-quarter and full-year 2024 guidance.

IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards

Retrieved on:

Mardi, avril 23, 2024

IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.

Key Points:

IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.
Wendy earned the award for her remarkable contributions to the healthcare industry, including her efforts in leading the teams responsible for the record-breaking delivery of COVID vaccine trials.
Susan has used her position and experiences as a mentor and role model to women throughout the business.
“Wendy and Susan represent the exceptional talent we have in the organization, exemplifying IQVIA’s values and serving as role models for all IQVIA employees,” said IQVIA Chairman and CEO Ari Bousbib.

IQVIA to Announce First-Quarter 2024 Results on May 2, 2024

Retrieved on:

Lundi, avril 15, 2024

Science, Software, Other Science, Biotechnology, Health, Data Management, Health Technology, Technology, IQVIA, ID, Webcast, IQV

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024.
The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day.
The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com .
To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com .

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

Retrieved on:

Lundi, avril 8, 2024

IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the #1 AI CRM, today announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.

Key Points:

IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Salesforce (NYSE:CRM), the #1 AI CRM, today announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.
Building on the IQVIA Orchestrated Customer Engagement ( OCE ) platform, launched in 2017, the partnership will apply innovations from IQVIA OCE with Salesforce’s Life Sciences Cloud to provide customers with a new single, end-to-end engagement platform.
As part of the expanded partnership, IQVIA will license the OCE CRM related software to Salesforce, and the parties will collaborate to accelerate development of Life Sciences Cloud for customer engagement, expected to be available in 2025*.
“Our collaboration with IQVIA marks a pivotal moment for Salesforce Life Sciences Cloud innovation.

IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024

Retrieved on:

Mercredi, mars 6, 2024

Research, Technology, Security, Health Technology, Software, Biotechnology, Pharmaceutical, Health, Data Management, Science, IQVIA, Barclays, IQV, Webcast, Conference

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024 at 9:30 a.m.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024 at 9:30 a.m.
ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com .
A replay of the webcast will be available later that day.

IQVIA Publishes its 2023 Environmental, Social and Governance Report

Retrieved on:

Lundi, février 26, 2024

IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report.

Key Points:

IQVIA™ (NYSE:IQV), has published its 2023 Environmental, Social and Governance (ESG) Report.
“We are proud that we delivered on our sustainability commitments despite the tumultuous macro-environment we have been operating in.”
IQVIA’s full 2023 ESG report can be downloaded here .
We established our dedicated global public health business in 2023, which now works with more than 75 clients across the globe.
For the third year in a row, IQVIA was named the number one most admired company in our category, Healthcare: Pharmacy and Other Services.

IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024

Retrieved on:

Mercredi, février 21, 2024

Technology, Biotechnology, Health, Other Health, Pharmaceutical, Other Science, Other Technology, Research, Medical Devices, Software, Health Technology, Science, Data Management, Security, IQVIA, IQV, Webcast

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at Citi’s 2024 Unplugged Medtech and Life Sciences Access Day in New York on Thursday, February 29, 2024 at 9:30 a.m.

Key Points:

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at Citi’s 2024 Unplugged Medtech and Life Sciences Access Day in New York on Thursday, February 29, 2024 at 9:30 a.m.
ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com .
A replay of the webcast will be available later that day.

IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

Retrieved on:

Mercredi, février 14, 2024

Data Management, Health, Technology, Research, Science, Artificial Intelligence, Biotechnology, DS, Free cash flow, Share repurchase, Growth, ID, Adjustment, RFP, TAS, GAAP, Webcast, COVID, IQV

As of December 31, 2023, R&DS contracted backlog, including reimbursed expenses, was $29.7 billion, growing 9.2 percent year-over-year and 8.8 percent at constant currency.

Key Points:

As of December 31, 2023, R&DS contracted backlog, including reimbursed expenses, was $29.7 billion, growing 9.2 percent year-over-year and 8.8 percent at constant currency.
"The IQVIA team delivered solid 2023 results in a challenging macro environment," said Ari Bousbib, chairman and CEO of IQVIA.
All financial guidance assumes foreign currency exchange rates as of February 12, 2024 remain in effect for the forecast period.
IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its fourth-quarter and full-year 2023 results and 2024 guidance.

IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year

Retrieved on:

Mardi, février 6, 2024

Research, Clinical Trials, Professional Services, Other Health, Biotechnology, Data Analytics, Pharmaceutical, Health, Science, Other Science, Social responsibility, IQVIA, Health care, Pharmacy, Korn Ferry, IQV

For the third year in a row IQVIA earned the first-place ranking within the Health Care: Pharmacy and Other Services category.

Key Points:

For the third year in a row IQVIA earned the first-place ranking within the Health Care: Pharmacy and Other Services category.
The company also ranked number one in six categories for quality of management, people management, innovation, quality of products and services, global competitiveness, and use of corporate assets.
Fortune® World's Most Admired Companies™ is the definitive report card on corporate reputation.
Since 1997, Fortune® has identified, selected, and ranked the World’s Most Admired Companies, identifying the business practices that make these companies highly regarded among their peers.